Proteasome Inhibitor–Loaded Micelles Enhance Antitumor Activity Through Macrophage Reprogramming by NF-κB Inhibition
Hailiang Wu(Innovation Center of NanoMedicine), Kazunori Kataoka(Innovation Center of NanoMedicine), Yoshihiro Hayakawa(Peter MacCallum Cancer Centre), John D. Martin(Harvard University), Horacio Cabral(The University of Tokyo), Tatsuro Irimura(Juntendo University), Yutaka Miura(Nagoya City University), Sabina Quader(Innovation Center of NanoMedicine), Xueying Liu(Innovation Center of NanoMedicine), Kei Takahashi(Howard Hughes Medical Institute), Louise Hespel(The University of Tokyo), Anqi Tao(The University of Tokyo)
Cited by 11
Related Papers
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.4k
Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges
|Annual Review of Physiology|2019|503
Ebolavirus Is Internalized into Host Cells via Macropinocytosis in a Viral Glycoprotein-Dependent Manner
|PLoS Pathogens|2010|444
Chemical Landscape for Tissue Clearing Based on Hydrophilic Reagents
|Cell Reports|2018|369